|Articles|May 13, 2014
PRA Adds Large Molecule Capabilities to US Laboratory
PRA announced the addition of capabilities and services to its Lenexa, KS location.
Advertisement
PRA, a clinical research organization, announced the addition of capabilities and services to its Lenexa, KS location. Now, in addition to the laboratory in Assen, The Netherlands offering full-service bioanalytical capabilities, the Lenexa, KS laboratory will now offer immunochemistry services. The additions solidify PRA as the only company in the world with full-service bioanalytical capabilities near its clinics to support rapid results from Phase I clinical studies in the US and Europe.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies
2
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
3
ACT Brief: Lean Development Through Fractional Teams and Partners, FDA Expedited IND Pilot for Phase I Acceleration, and Tudriqev Accelerated Approval for Anti-PD-1-Refractory Melanoma
4
ACT Brief: Commercial Strategy Shaping Early Clinical Development, Real-Time Trials Require Operational Infrastructure, and AI Site Engagement Gap
5